Sponsor

Klinikum der Universitaet Muenchen AöR

Germany Leopoldstrasse 5, Maxvorstadt, 80802 Munich, Germany

About the sponsor

Research activity includes acute myeloid leukemia, mantle cell lymphoma, and other B-cell lymphoma settings, with interest in cellular and immunologic treatment strategies.

CAR-T-cell therapy
Bispecific antibody combinations
Targeted treatment in relapsed and frontline disease

Trial activity also extends to transplant-related approaches and treatment selection in biologically high-risk lymphoma.

About Specializations

Klinikum der Universitaet Muenchen AöR runs clinical trials in conditions such as Hepatocellular carcinoma, Mantle cell lymphoma stage II, Mantle cell lymphoma stage III, Mantle cell lymphoma stage IV, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Quick filters

16 clinical trials

Vestibular disorder

Recruiting

A study to evaluate the use of levothyroxine sodium in patients with sudden onset of dizziness caused by inner ear issues.

Registered drug

A study to evaluate the use of levothyroxine sodium in patients with sudden onset of dizziness caused by inner ear issues.

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Levothyroxine Sodium
Sponsor:Klinikum der Universitaet Muenchen AöR

Contact Research Centre

Mantle cell lymphoma

Recruiting

Study of Glofitamab and Pirtobrutinib Treatment in Patients with Mantle Cell Lymphoma Who Have Failed Previous Therapy and in Previously Untreated Patients

Registered drugNo placebo

Study of Glofitamab and Pirtobrutinib Treatment in Patients with Mantle Cell Lymphoma Who Have Failed Previous Therapy and in Previously Untreated Patients

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Glofitamab
Sponsor:Klinikum der Universitaet Muenchen AöR

Contact Research Centre

Transcatheter aortic valve implantation

Recruiting

Study on Protamine Sulfate for Reducing Bleeding and Ischemic Events in Adults with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

Registered drug

Study on Protamine Sulfate for Reducing Bleeding and Ischemic Events in Adults with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

Registered drug

Austria

Participants:18–64 years · 65+ years
Substances:Protamine Sulfate
Sponsor:Klinikum der Universitaet Muenchen AöR

Contact Research Centre

Hepatocellular carcinoma

Recruiting

Study on the Effect of Durvalumab and Tremelimumab with Radioactive Glass Spheres in Patients with Non-Resectable Liver Cancer

Registered drugNo placebo

Study on the Effect of Durvalumab and Tremelimumab with Radioactive Glass Spheres in Patients with Non-Resectable Liver Cancer

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Durvalumab
Sponsor:Klinikum der Universitaet Muenchen AöR

Contact Research Centre

Schizophrenia

Recruiting

Study on Clemastine and Aerobic Exercise for Improving Cognitive Function in Schizophrenia Patients

Registered drug

Study on Clemastine and Aerobic Exercise for Improving Cognitive Function in Schizophrenia Patients

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Clemastine
Sponsor:Klinikum der Universitaet Muenchen AöR

Contact Research Centre

Ischaemic stroke

Recruiting

Study on Reducing Inflammation in Acute Ischemic Stroke Patients Using Dornase Alfa and Sodium Chloride

Registered drug

Study on Reducing Inflammation in Acute Ischemic Stroke Patients Using Dornase Alfa and Sodium Chloride

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Dornase Alfa
Sponsor:Klinikum der Universitaet Muenchen AöR

Contact Research Centre

Chronic hepatitis B

Recruiting

Study on the Safety and Efficacy of a Hepatitis B Vaccine with Hepatitis B Surface Antigen (rDNA), MVA-HBVAC, and Mosaic HBcoreAg for Adults with Chronic Hepatitis B

InvestigationalNo placebo